FDA approves Bristol-Myers’s skin cancer treatment Opdivo
December 22, 2014 at 18:09 PM EST
Company expected to charge $12,500 a month for drug to fight lethal late stage melanoma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.